Epidemiology and In Vitro Activity of Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam against <i>KPC</i>-Producing <i>K. pneumoniae</i> Collected from Bacteremic Patients, 2018 to 2020

Epidemiology and In Vitro Activity of Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam against <i>KPC</i>-Producing <i>K. pneumoniae</i> Collected from Bacteremic Patients, 2018 to 2020

The management of KPC-producing <i>K. pneumoniae</i> (KPC-Kp) in bloodstream infections (BSIs) represent a serious clinical challenge. In this study, the aim is to assess the incidence of resistance to novel β-lactams-β-lactamase inhibitor combinations (βL-βLICs), such as ceftazidime-avi...

Full description

Bibliographic Details
Main Authors: Federica Bovo, Donatella Lombardo, Tiziana Lazzarotto, Simone Ambretti, Paolo Gaibani
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Antibiotics
Subjects:
BL-BLICs
resistance
enterobacteriales
whole-genome sequencing
Online Access:https://www.mdpi.com/2079-6382/11/11/1621

Internet

https://www.mdpi.com/2079-6382/11/11/1621

Similar Items